文献速递神经MR

T1 mapping评估退行性颈髓病脊髓微结构

T1 Mapping for Microstructural Assessment of the Cervical Spinal Cord in the Evaluation of Patients with Degenerative Cervical Myelopathy.
PubMed 文献 · AJNR Am J Neuroradiol · 2021-05-13

轻度患者与健康对照差异不显著。

要点

  • 中重度退行性颈髓病患者颈髓T1值升高,C1非狭窄层面亦受累。
  • T1值与mJOA评分强负相关,可作为临床严重程度的候选定量生物标志物。
  • 轻度患者T1值变化不显著,需多中心大样本进一步验证。

关键影像表现/征象

  • 健康对照非压迫层面T1值显著低于患者的非压迫、轻度、中度和重度狭窄层面。
  • 中重度患者全脊髓T1值高于健康对照,C1、C7及最大压迫层面T1值升高。
  • 轻度患者最大压迫层面T1值低于中重度患者,但与健康对照差异不显著。
  • 白质和前角灰质分析结果与全局脊髓一致。

诊断标准与关键数值

  • 中重度退行性颈髓病患者与健康对照相比,全脊髓T1值升高。
  • 中重度患者C1、C7及最大压迫层面T1值较健康对照升高。
  • 轻度患者最大压迫层面T1值低于中重度患者。
  • 个体mJOA评分与T1值呈强负相关。

临床应用与阅片要点

  • T1 mapping可补充常规MRI,评估颈髓弥漫性微结构改变,尤其在非压迫层面。
  • 报告时可关注C1和最大压迫层面的T1值变化,结合mJOA评分。
  • 轻度患者T1值变化不显著,解读时需谨慎,避免过度诊断。

局限性

  • 单中心设计,结果需多中心大样本验证。
  • 轻度患者与健康对照差异不显著,需进一步研究。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

BACKGROUND AND PURPOSE: Although current radiologic evaluation of degenerative cervical myelopathy by conventional MR imaging accurately demonstrates spondylosis or degenerative disc disease causing spinal cord dysfunction, conventional MR imaging still fails to provide satisfactory anatomic and clinical correlations. In this context, we assessed the potential value of quantitative cervical spinal cord T1 mapping regarding the evaluation of patients with degenerative cervical myelopathy.

MATERIALS AND METHODS: Twenty patients diagnosed with mild and moderate-to-severe degenerative cervical myelopathy and 10 healthy subjects were enrolled in a multiparametric MR imaging protocol. Cervical spinal cord T1 mapping was performed with the MP2RAGE sequence procedure. Retrieved data were processed and analyzed regarding the global spinal cord and white and anterior gray matter on the basis of the clinical severity and the spinal canal stenosis grading.

RESULTS: Noncompressed levels in healthy controls demonstrated significantly lower T1 values than noncompressed, mild, moderate, and severe stenotic levels in patients. Concerning the entire spinal cord T1 mapping, patients with moderate-to-severe degenerative cervical myelopathy had higher T1 values compared with healthy controls. Regarding the specific levels, patients with moderate-to-severe degenerative cervical myelopathy demonstrated a T1 value increase at C1, C7, and the level of maximal compression compared with healthy controls. Patients with mild degenerative cervical myelopathy had lower T1 values than those with moderate-to-severe degenerative cervical myelopathy at the level of maximal compression. Analyses of white and anterior gray matter confirmed similar results. Strong negative correlations between individual modified Japanese Orthopaedic Association scores and T1 values were also observed.

CONCLUSIONS: In this preliminary study, 3D-MP2RAGE T1 mapping demonstrated increased T1 values in the pathology tissue samples, with diffuse medullary alterations in all patients with degenerative cervical myelopathy, especially relevant at C1 (nonstenotic level) and at the maximal compression level. Encouraging correlations observed with the modified Japanese Orthopaedic Association score make this novel approach a potential quantitative biomarker related to clinical severity in degenerative cervical myelopathy. Nevertheless, patients with mild degenerative cervical myelopathy demonstrated nonsignificant results compared with healthy controls and should now be studied in multicenter studies with larger patient populations.

来源:AJNR Am J Neuroradiol,查看原文。版权归原作者所有。

引用

  1. Baucher G, Rasoanandrianina H, Levy S, et al. T1 Mapping for Microstructural Assessment of the Cervical Spinal Cord in the Evaluation of Patients with Degenerative Cervical Myelopathy. AJNR Am J Neuroradiol. 2021. PMID: 33985954. doi:10.3174/ajnr.A7157

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。